Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines
An
Xiao
,
Xiu-Jing
Zheng
,
Chengcheng
Song
,
Yue
Gui
,
Chang-Xin
Huo
and
Xin-Shan
Ye
*
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xue Yuan Road No. 38, Beijing 100191, China. E-mail: xinshan@bjmu.edu.cn; Fax: (+86) 10-82802724; Tel: (+86) 10-82805736
First published on 14th February 2017
Abstract
Correction for ‘Synthesis and immunological evaluation of MUC1 glycopeptide conjugates bearing N-acetyl modified STn derivatives as anticancer vaccines’ by An Xiao et al., Org. Biomol. Chem., 2016, 14, 7226–7237.
The authors regret that there were some errors in Scheme 4. The correct scheme is shown below.
 | ||
| Scheme 1 Solid-phase synthesis of the STn-MUC1 glycopeptides and their conjugation to the carrier protein KLH to afford vaccine candidates V1–V4. Fmoc = fluorenyl-9-methoxycarbonyl, HATU = O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium hexafluorophosphate, HOAt = N-hydroxy-7-azabenzotriazole, NMM = N-methylmorpholine, TFA = trifluoroacetic acid, TIS = triisopropylsilane, KLH = keyhole limpet hemocyanin. | ||
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2017 |